SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME

Clinical trials for SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME trials appear

Sign up with your email to follow new studies for SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

CBD tested in infants with rare, severe seizure disorders

Disease control Terminated

This study aimed to test the safety and effectiveness of a cannabidiol (CBD) oral solution in babies under 2 years old with severe, hard-to-control epilepsy syndromes. It was designed to see if adding CBD to their current medications could help reduce their seizures. The study wa…

Matched conditions: SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME

Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME

Get alerted when new SEIZURE IN PARTICIPANTS WITH DRAVET SYNDROME trials appear

CBD tested in infants with rare, severe seizure disorders